SILK Laser (ASX:SLA) share price edges lower on quarterly update

The laser clinic company expects a strong rebound in business as COVID-19 restrictions ease

The SILK Laser Australia Ltd (ASX: SLA) share price is in the red on Thursday morning after the company announced a resilient first-quarter trading update.

At the time of writing, the SILK Laser share price is down 0.75% to $4.61.

A woman lies down with eyes closed as she prepares to receive a cosmetic injectable in her face.

Image source: Getty Images

SILK Laser share price down as COVID-19 restrictions bite

SILK Laser delivered a resilient performance over the first quarter ended 30 September. Some highlights include:

  • Network cash sales adjusted for lost trading days up 14% to $23.5 million;
  • Unadjusted network cash sales down 4%;
  • Like-for-like sales adjusted for lost trading days up 2% to $20.4 million; and
  • Unadjusted like-for-like sales down 14%.

SILK was pleased with its FY22 year-to-date performance considering the lost trading days due to closed clinics during COVID-19 lockdowns. It also comes against the backdrop of an exceptionally strong comparable period last year.

The trading update highlighted strong growth across body and injectable categories, with its overall service mix evolving, as planned.

Online sales for SILK's skincare brands surged by 700% to about $189,000, although this came off a low base.

Back in September, the company announced it had completed the acquisition of Australian Skin Clinics (ASC), which pushed the SILK Laser share price higher at the time. The company advised the integration of ASC is on track.

ASC's financial performance was not included in SILK's Q1 sales metrics given its 4 weeks of ownership.

Management commentary

SILK founder and managing director Martin Perelman commented on the first-quarter results, saying:

We are pleased with how the business has performed over the first three months of FY22. While COVID lockdowns again held back sales growth as clinics were forced to close, on an adjusted basis we saw strong momentum in key growth categories, resulting in overall positive like-for-like sales growth. In particular, SILK experienced strong growth across its body and injectables categories, and exceptional growth in online sales of our skincare brands.

What's next for SILK?

SILK is positive on its outlook, citing the majority of NSW clinics achieved the equivalent of approximately two weeks' worth of trading within the first week of opening after lockdowns.

"Cosmetic Injectables, as has happened previously, performed far above expectations driven by strong waitlists and the strength of SILK's injecting teams."

Its service and earnings mix is expected to continue to evolve with a growing position in injectable and body categories. SILK said it will continue to roll out these service offerings across its network.

Despite a challenging trading environment so far in 2021, the SILK Laser share price is up 29% year-to-date.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended SILK Laser Australia Limited. The Motley Fool Australia has recommended SILK Laser Australia Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Sad man sitting at desk and grabbing his head as he looks at a laptop.
ASX Share Market News

5 things to watch on the ASX 200 on Thursday

Investors might want to load their PlayStations and avoid another potential red day on the market today.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Opinions

My 3 biggest ASX portfolio winners and the one I'm buying more of

These businesses have significant growth potential.

Read more »

A man rests his chin in his hands, pondering what is the answer?
ASX Share Market News

Think you know the ASX? Try guessing the top 20 ASX shares of the past 20 years

Alongside the familiar names sit a couple of surprising names whose massive gains were supercharged by where they started two…

Read more »

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »